Therapeutic Apheresis and Dialysis

Published on behalf of The International Society for Apheresis, The Japanese Society for Apheresis and The Japanese Society for Dialysis Therapy

Edited by:
Tadao Akizawa, Yukihiko Nosé, Wolfgang Ramlow, Akio Kawamura, Hajime Inamoto, Akinori Sueoka, Paul S. Malchesky, Angela T. Hadsell

ISI Journal Citation Reports® Ranking: 2007: 53/63 (Hematology); 42/55 (Urology & Nephrology)
Impact Factor: 1.225

---

 Published bi-monthly, Therapeutic Apheresis and Dialysis recognises the value of apheresis treatment in many fields of medicine. Publishing content spanning medicine, biology, biophysics, and engineering with a particular emphasis on how they converge in the development of new technologies and treatments resulting in improved patient outcomes.

The Journal is published on behalf of International Society for Apheresis, The Japanese Society for Apheresis and The Japanese Society for Dialysis Therapy. Manuscripts can be submitted online via manuscript Central.

TopNews and Announcements

View Articles Free Online

• Review Article: Clinical Experience With Prometheus
  Kinan Rifai and Michael P Manns
• Read an entire issue free online

Online Manuscript Submission Now Available
Submit your manuscript online at Manuscript Central.

Free Access in the Developing World
Free online access to this journal is available within institutions in the developing world through the HINARI initiative with the World Health Organization (WHO).

NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate,  please visit our policy statement. 

 

TopHighlights

Popular Articles from Therapeutic Apheresis and Dialysis

Diagnosis and Treatment of Depression in Dialysis Patients

Review Article: Clinical Experience With Prometheus [Most read]

Therapeutic Apheresis - State of the Art in the Year 2005 [Highly cited and downloaded]

Regular Exercise as a Part of Treatment for Patients With End-stage Renal Disease

Bioartificial Liver: Its Pros and Cons

Therapeutic Strategy and the Role of Apheresis Therapy for ABO Incompatible Living Donor Liver Transplantation